Premarket trading highlights earnings-driven moves in Pfizer, Palantir and Apple
Premarket trading is showing sharp investor reactions to a fresh round of quarterly updates across healthcare, technology and consumer stocks. Gains in Revvity and Yum Brands contrast with declines in Palantir, Apple and Zebra Technologies as markets weigh guidance, margins and revenue trends.
Highlights
- Revvity jumps 7% in premarket after raising full-year pro forma adjusted EPS guidance to $5.40-$5.45 from $5.30-$5.40.
- Palantir falls nearly 8% premarket despite Q3 earnings beat, as investors react to outlook with $2.65 billion Q4 and $8.53 billion FY2026 revenue projections.
- Apple drops almost 4% premarket following a weaker-than-expected margin forecast and fiscal Q4 iPad sales missing analyst estimates.
Quarterly results drive early trading
As reported by CNBC, several major U.S. stocks are posting notable premarket moves after releasing quarterly earnings and updated outlooks.Revvity shares gain 7% after the life sciences company raises its full-year pro forma adjusted earnings per share guidance to $5.40 to $5.45, up from a prior range of $5.30 to $5.40. Pfizer trades roughly flat after reporting third-quarter results of 87 cents per share, excluding certain items, on revenue of $16.58 billion, ahead of LSEG analyst expectations for 73 cents per share and $15.87 billion in revenue.
Zebra Technologies falls more than 6% even after posting third-quarter results above expectations. The company reports adjusted earnings of $4.95 per share on revenue of $1.61 billion, compared with FactSet forecasts of $4.89 per share and $1.57 billion, while its full-year free cash flow guidance of at least $1 billion comes in slightly below a $1.02 billion estimate.
Gartner shares slide more than 6% despite third-quarter results that beat expectations and full-year earnings and revenue guidance that also top forecasts. Yum Brands rises 1% after adjusted third-quarter earnings of $1.56 per share beat the $1.49 expected by analysts polled by LSEG, while revenue of $2.05 billion matches consensus estimates.
Technology names face pressure on outlooks
Palantir Technologies drops nearly 8% even though its third-quarter earnings exceed Wall Street estimates. The company says U.S. commercial revenue jumps 148% to $984 million, surpassing U.S. government revenue of $953 million, and it projects about $2.65 billion in fourth-quarter revenue and $8.53 billion for full-year 2026.Apple shares fall nearly 4% in premarket trading after the company reports a disappointing margin forecast and fiscal fourth-quarter iPad sales that miss Street estimates. The moves suggest investors are focusing more heavily on forward profitability and segment performance than on headline earnings beats alone.
For broader sector sentiment, the mixed premarket reactions show that better-than-expected quarterly figures are not consistently enough to lift shares when guidance, cash flow or margin signals disappoint. That pattern is especially visible in technology and equipment names, where expectations remain high and outlook changes carry added weight.
Our earlier coverage of the S&P 500’s pullback highlighted how earnings-season reactions—led by technology and AI names—were unfolding alongside pressure from rising Treasury yields. We noted the index was trading below key short- and medium-term moving averages, pointing to broader selling pressure and the risk of choppy consolidation unless key technical levels were reclaimed.